Delivery Order SPE2DB20D7059-SPE2DB25FGTL5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,572.48 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on September 3, 2025, with an ultimate completion date of September 4, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $10,266.71 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray. This contract, which was competitively awarded with no set-aside designation, has a firm fixed price structure and an ultimate completion date of August 18, 2025. The product will be delivered to a location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,183.68 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-pack units) on September 12, 2025, with completion targeted for September 15, 2025. This firm fixed-price delivery order, which carried no set-aside designation, represents a competitive award under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a delivery order valued at $1,124.16 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray (2-count units) on August 22, 2025, with completion scheduled for August 25, 2025. This firm fixed price contract was awarded competitively with no set-aside designation and is being performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $17,364.04 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on June 18, 2025, with an ultimate completion date of June 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency awarded a delivery order valued at $5,820.47 to AmerisourceBergen Drug Corp for the supply of Naloxone HCL 4 mg nasal spray on September 5, 2025, with an ultimate completion date of September 8, 2025. This firm fixed-price delivery order represents a non-set-aside award, indicating it was competitively awarded. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. Naloxone is a critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,470.53 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $1,519.77 to AmerisourceBergen Drug Corp for Naloxone HCl 4 mg nasal spray (2-count units) on August 18, 2025, with completion targeted for August 19, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework. Performance will be executed from the company's Conshohocken, Pennsylvania location,...
- The Defense Logistics Agency awarded a delivery order valued at $1,191.84 to AmerisourceBergen Drug Corp for Naloxone HCL 4 mg nasal spray on August 21, 2025, with an ultimate completion date of August 22, 2025. This firm fixed price delivery order, which was competitively awarded without set-aside designation, is to be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Naloxone is a critical opioid antagonist medication used in emergency medical response and...
- The Defense Logistics Agency awarded a delivery order valued at $1,480.17 to AmerisourceBergen Drug Corp for the supply of Naloxone HCl 4 mg nasal spray (two-pack units) on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB25FGTL5Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,189.90 for Naloxone HCl 4 mg nasal spray on September 26, 2025, with an ultimate completion date of September 29, 2025. This firm fixed-price delivery order is not set-aside and will be performed in Conshohocken, Pennsylvania, where the awardee maintains its corporate headquarters. The product represents critical medical supply for overdose reversal, which supports the agency's pharmaceutical procurement mission across the Defense Health System and military healthcare operations. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp demonstrates significant capacity to fulfill diverse pharmaceutical requirements through competitive, open-market contracts with the Defense Logistics Agency. The company's extensive portfolio of federal contracts reflects its role as a critical vendor supplying medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 9/26/25 |